Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-01

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality.

We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.

NCT04608149

Acute Kidney Injury Fluid Overload

ACTIVE_NOT_RECRUITING

Heparin Free Haemodialysis With Haemodialyzers "VIE" Versus "EVODIAL"

NCT01221337

Adult Chronic Haemodialysis Patients Since at Least 3 Months

COMPLETED NA

Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury

NCT01569698

Kidney Failure, Acute

TERMINATED

Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients

NCT01327391

Cardiovascular Disease

COMPLETED PHASE4

Percutaneous Anastomosis Creation for Hemodialysis Access

NCT05897996

D001159

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxic-Ischemic Encephalopathy Sepsis Kidney Diseases Metabolic Disease Twin to Twin Transfusion Syndrome Cardiac Disease Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

We have included 25 neonates and small infants having received CARPEDIEM® machine in France in a multicentric experience

CARPEDIEN

Intervention Type DEVICE

Continuous renal replacement therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CARPEDIEN

Continuous renal replacement therapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children and neonates including premature and low birth weight neonates
* Have a diagnosis of acute kidney injury, end stage renal disease, metabolic disease, electrolyte abnormality
* Require renal replacement therapy